Inside the GLP-1 Gold Rush: Eli Lilly CEO on New Breakthroughs, Addiction & Mental Health, Pricing
Listen to the original audio · Transcribed with NVIDIA Parakeet · Timestamps stay in sync with the live audio
GLP1 drugs have become increasingly popular. Eli Lilly coming to save us here has had its market capitalization increase by about 860% since he became CEO, and the stock price is up a little bit more than a thousand percent. No need for needles. Eli Lilly says it has a pill. Eli Lilly's experimental pill appears to work as well as the injected drug.
It's everyone's job to move the science. We should always be pushing forward. Ladies and gentlemen, please welcome Edeline Lilly's CEO Dave Ricks. Hi doing Dave.
Hi David, good to see you. Good to see you. All right. How are you? Dave, all right.
We already have this episode, so unlocking it is cheap and permanent: the full transcript (31 minutes, 6,022 words), segment and word-level timestamps, and .txt, .srt, .vtt and word-level JSON downloads, as many times as you like, forever.
No account needed, we create one from your checkout email. With credits it is 1 credit; packs start at 10 episodes for $5, and monthly plans are cheaper still.